Universe Pharmaceuticals (UPC) Competitors $3.74 +0.13 (+3.60%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock UPC vs. NCNA, BPTSY, VRPX, KRBP, MYMD, TFFP, SMFL, TCBP, CAPS, and VINCShould you be buying Universe Pharmaceuticals stock or one of its competitors? The main competitors of Universe Pharmaceuticals include NuCana (NCNA), Biophytis (BPTSY), Virpax Pharmaceuticals (VRPX), Kiromic BioPharma (KRBP), MyMD Pharmaceuticals (MYMD), TFF Pharmaceuticals (TFFP), Smart for Life (SMFL), TC Biopharm (TCBP), Capstone Therapeutics (CAPS), and Vincerx Pharma (VINC). These companies are all part of the "pharmaceutical products" industry. Universe Pharmaceuticals vs. Its Competitors NuCana Biophytis Virpax Pharmaceuticals Kiromic BioPharma MyMD Pharmaceuticals TFF Pharmaceuticals Smart for Life TC Biopharm Capstone Therapeutics Vincerx Pharma Universe Pharmaceuticals (NASDAQ:UPC) and NuCana (NASDAQ:NCNA) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability, media sentiment and risk. Does the media prefer UPC or NCNA? In the previous week, Universe Pharmaceuticals' average media sentiment score of 0.00 equaled NuCana'saverage media sentiment score. Company Overall Sentiment Universe Pharmaceuticals Neutral NuCana Neutral Which has more volatility and risk, UPC or NCNA? Universe Pharmaceuticals has a beta of 1.43, meaning that its share price is 43% more volatile than the S&P 500. Comparatively, NuCana has a beta of 1.42, meaning that its share price is 42% more volatile than the S&P 500. Do institutionals and insiders hold more shares of UPC or NCNA? 0.2% of Universe Pharmaceuticals shares are held by institutional investors. Comparatively, 44.0% of NuCana shares are held by institutional investors. 57.4% of Universe Pharmaceuticals shares are held by company insiders. Comparatively, 31.2% of NuCana shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts recommend UPC or NCNA? NuCana has a consensus target price of $25.00, suggesting a potential upside of 44,383.99%. Given NuCana's stronger consensus rating and higher possible upside, analysts plainly believe NuCana is more favorable than Universe Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Universe Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00NuCana 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has better earnings and valuation, UPC or NCNA? Universe Pharmaceuticals has higher revenue and earnings than NuCana. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUniverse Pharmaceuticals$23.02M0.01-$8.73MN/AN/ANuCanaN/AN/A-$24.28M-$7.02-0.01 Is UPC or NCNA more profitable? Universe Pharmaceuticals' return on equity of 0.00% beat NuCana's return on equity.Company Net Margins Return on Equity Return on Assets Universe PharmaceuticalsN/A N/A N/A NuCana N/A -319.85%-88.55% SummaryUniverse Pharmaceuticals beats NuCana on 6 of the 10 factors compared between the two stocks. Get Universe Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for UPC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding UPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPC vs. The Competition Export to ExcelMetricUniverse PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$150K$2.37B$5.47B$8.92BDividend YieldN/A1.78%5.24%4.04%P/E RatioN/A8.9227.0520.14Price / Sales0.01501.68380.7693.83Price / CashN/A21.7726.2128.59Price / Book0.004.528.005.58Net Income-$8.73M$31.26M$3.16B$248.40M7 Day Performance-1.58%6.11%3.84%6.13%1 Month Performance-12.82%5.75%3.04%7.78%1 Year PerformanceN/A1.24%34.26%20.95% Universe Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPCUniverse PharmaceuticalsN/A$3.74+3.6%N/AN/A$150K$23.02M0.00220NCNANuCana2.5288 of 5 stars$0.09+4.0%$25.00+29,003.6%-98.2%$500KN/A-0.0130Gap UpBPTSYBiophytisN/A$1.38flatN/A-78.6%$484KN/A0.0030VRPXVirpax Pharmaceuticals1.3452 of 5 stars$0.32+4.8%$75.00+23,709.5%-97.3%$391KN/A0.007Gap DownKRBPKiromic BioPharmaN/AN/AN/AN/A$330KN/A-0.0660Gap DownHigh Trading VolumeMYMDMyMD PharmaceuticalsN/A$0.13+3.6%N/A-93.5%$308KN/A0.006High Trading VolumeTFFPTFF PharmaceuticalsN/A$0.07flatN/AN/A$289K$730K-0.0119SMFLSmart for LifeN/A$0.04flatN/AN/A$284K$11.11M0.00110Gap DownTCBPTC BiopharmN/A$0.68-55.8%$48.00+6,948.5%-99.5%$279K$4.76M0.0080High Trading VolumeCAPSCapstone TherapeuticsN/A$1.67-1.8%N/AN/A$270K$44.88M0.0038Positive NewsVINCVincerx Pharma2.4582 of 5 stars$0.05-9.1%$40.00+79,900.0%-99.7%$262KN/A0.0060News CoverageGap Down Related Companies and Tools Related Companies NuCana Alternatives Biophytis Alternatives Virpax Pharmaceuticals Alternatives Kiromic BioPharma Alternatives MyMD Pharmaceuticals Alternatives TFF Pharmaceuticals Alternatives Smart for Life Alternatives TC Biopharm Alternatives Capstone Therapeutics Alternatives Vincerx Pharma Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:UPC) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Universe Pharmaceuticals INC Please log in to your account or sign up in order to add this asset to your watchlist. Share Universe Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
